Agilent Technologies Inc. has introduced the Agilent SurePrint G3 Human Gene-Expression v2 Microarray, the only product available with an array of probes designed using the Broad Institute’s recently ...
In the post-genomic era, long non-coding RNAs (lncRNAs) have emerged as critical regulators in various cancers and hold potential as minimally invasive diagnostic biomarkers. This study aimed to ...
We offer genotyping and microarray gene expression analyses using Thermofisher (formerly known as Affymetrix) array platforms. We are one of only a handful of labs in Europe to offer high throughput ...
Precision Treatment of Patients With GI Cancer Using Pre-emptive DPYD Genotyping/Phenotyping Plus Pharmacokinetic-Guided Dosing of 5-Fluorouracil Primary PCa biopsy samples underwent ...
Chicago, April 03, 2024 (GLOBE NEWSWIRE) -- Gene Expression Analysis market in terms of revenue was estimated to be worth $4.2 billion in 2024 and is poised to reach $6.2 billion by 2029, growing at a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results